-
Symbol
-
CTNM on Nasdaq
-
Investment type
-
Equity / Class A Common Stock, par value $0.001 per share
-
Latest Disclosed Ownership
-
2.12M shares
-
Security Ownership
-
9.9%
RA Capital Management, L.P. ownership in Contineum Therapeutics, Inc. Class A Common Stock, par value $0.001 per share (CTNM)
2025-07-25 - RA Capital Management, L.P. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.12M shares of Contineum Therapeutics, Inc. Class A Common Stock, par value $0.001 per share (CTNM).
This represents 9.9% percent ownership of the company.